Invacare (IVCRQ) versus Its Rivals Critical Survey

Invacare (NYSE:IVCRQ – Get Rating) is one of 50 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its rivals? We will compare Invacare to similar businesses based on the strength of its profitability, risk, institutional ownership, analyst recommendations, valuation, dividends and earnings.

Profitability

This table compares Invacare and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Invacare	-9.99%	-37.76%	-7.18%
Invacare Competitors	-205.57%	-85.94%	-23.03%

Valuation & Earnings

This table compares Invacare and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Invacare	$872.46 million	-$45.56 million	-0.01
Invacare Competitors	$1.21 billion	$110.89 million	7.64

Invacare’s rivals have higher revenue and earnings than Invacare. Invacare is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

Invacare has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Comparatively, Invacare’s rivals have a beta of 0.85, indicating that their average share price is 15% less volatile than the S&P 500.

Insider & Institutional Ownership

59.9% of Invacare shares are owned by institutional investors. Comparatively, 42.6% of shares of all “Surgical appliances & supplies” companies are owned by institutional investors. 6.9% of Invacare shares are owned by insiders. Comparatively, 11.9% of shares of all “Surgical appliances & supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and price targets for Invacare and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Invacare	0	0	0	0	N/A
Invacare Competitors	290	1066	2251	78	2.57

As a group, “Surgical appliances & supplies” companies have a potential upside of 26.39%. Given Invacare’s rivals higher probable upside, analysts clearly believe Invacare has less favorable growth aspects than its rivals.

Summary

Invacare rivals beat Invacare on 6 of the 10 factors compared.

Invacare Company Profile

(Get Rating)

Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.